320 related articles for article (PubMed ID: 36178064)
1. Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies.
Wang H; Wu S; Li Z; Zhang C; Shang X; Zhao C; Li Z; Lin J; Guo J; Wang Z
Cancer Sci; 2023 Feb; 114(2):665-679. PubMed ID: 36178064
[TBL] [Abstract][Full Text] [Related]
2. Transitioning to a Personalized Approach in Molecularly Subtyped Small-Cell Lung Cancer (SCLC).
Grenda A; Krawczyk P; Obara A; Gajek Ł; Łomża-Łaba A; Milanowski J
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673793
[TBL] [Abstract][Full Text] [Related]
3. Potential subtype-specific therapeutic approaches in small cell lung cancer.
Horvath L; Lang C; Boettiger K; Aigner C; Dome B; Megyesfalvi Z
Curr Opin Oncol; 2024 Jan; 36(1):51-56. PubMed ID: 37865844
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
5. New Therapies and Biomarkers: Are We Ready for Personalized Treatment in Small Cell Lung Cancer?
Zhang B; Birer SR; Dvorkin M; Shruti J; Byers L
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-10. PubMed ID: 33979194
[TBL] [Abstract][Full Text] [Related]
6. Genomic based analyses reveal unique mutational profiling and identify prognostic biomarker for overall survival in Chinese small-cell lung cancer.
Wang Y; Han X; Wang X; Sheng W; Chen Z; Shu W; Han J; Zhao S; Dai Y; Wang K; Shi W; Yang Z
Jpn J Clin Oncol; 2019 Dec; 49(12):1143-1150. PubMed ID: 31612912
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer.
Park S; Hong TH; Hwang S; Heeke S; Gay CM; Kim J; Jung HA; Sun JM; Ahn JS; Ahn MJ; Cho JH; Choi YS; Kim J; Shim YM; Kim HK; Byers LA; Heymach JV; Choi YL; Lee SH; Park K
EBioMedicine; 2024 Apr; 102():105062. PubMed ID: 38492534
[TBL] [Abstract][Full Text] [Related]
8. Intratumor heterogeneity is associated with less CD8
Zhang C; Li Z; Shang X; Zhao C; Wang H
Clin Transl Oncol; 2023 Apr; 25(4):1043-1052. PubMed ID: 36422799
[TBL] [Abstract][Full Text] [Related]
9. Origins, genetic landscape, and emerging therapies of small cell lung cancer.
Semenova EA; Nagel R; Berns A
Genes Dev; 2015 Jul; 29(14):1447-62. PubMed ID: 26220992
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.
Thomas A; Mian I; Tlemsani C; Pongor L; Takahashi N; Maignan K; Snider J; Li G; Frampton G; Ali S; Kim S; Nichols S; Rajapakse V; Guha U; Sharon E; Fujimoto J; Moran CA; Wistuba II; Wei JS; Khan J; Szabo E; Torres AZ; Carson KR
Chest; 2020 Oct; 158(4):1723-1733. PubMed ID: 32464188
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer.
Ross JS; Wang K; Elkadi OR; Tarasen A; Foulke L; Sheehan CE; Otto GA; Palmer G; Yelensky R; Lipson D; Chmielecki J; Ali SM; Elvin J; Morosini D; Miller VA; Stephens PJ
J Clin Pathol; 2014 Sep; 67(9):772-6. PubMed ID: 24978188
[TBL] [Abstract][Full Text] [Related]
12. Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer.
Zhou H; Hu Y; Luo R; Zhao Y; Pan H; Ji L; Zhou T; Zhang L; Long H; Fu J; Wen Z; Wang S; Wang X; Lin P; Yang H; Wang J; Song M; Yi X; Yang L; Xia X; Guan Y; Fang W; Yang Y; Hong S; Huang Y; Li P; Zhang Y; Zhou N
Nat Commun; 2021 Sep; 12(1):5431. PubMed ID: 34521849
[TBL] [Abstract][Full Text] [Related]
13. Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.
Udagawa H; Umemura S; Murakami I; Mimaki S; Makinoshima H; Ishii G; Miyoshi T; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuchihara K; Goto K
Lung Cancer; 2018 Dec; 126():182-188. PubMed ID: 30527185
[TBL] [Abstract][Full Text] [Related]
14. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
Heeke S; Gay CM; Estecio MR; Tran H; Morris BB; Zhang B; Tang X; Raso MG; Rocha P; Lai S; Arriola E; Hofman P; Hofman V; Kopparapu P; Lovly CM; Concannon K; De Sousa LG; Lewis WE; Kondo K; Hu X; Tanimoto A; Vokes NI; Nilsson MB; Stewart A; Jansen M; Horváth I; Gaga M; Panagoulias V; Raviv Y; Frumkin D; Wasserstrom A; Shuali A; Schnabel CA; Xi Y; Diao L; Wang Q; Zhang J; Van Loo P; Wang J; Wistuba II; Byers LA; Heymach JV
Cancer Cell; 2024 Feb; 42(2):225-237.e5. PubMed ID: 38278149
[TBL] [Abstract][Full Text] [Related]
15. Genomic features of Chinese small cell lung cancer.
Liu J; Zhao Z; Wei S; Li B; Zhao Z
BMC Med Genomics; 2022 May; 15(1):117. PubMed ID: 35596192
[TBL] [Abstract][Full Text] [Related]
16. SCLC-State of the Art and What Does the Future Have in Store?
Kahnert K; Kauffmann-Guerrero D; Huber RM
Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
[TBL] [Abstract][Full Text] [Related]
17. Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations.
Zhang C; Wang H
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188798. PubMed ID: 36096336
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential.
Hu J; Wang Y; Zhang Y; Yu Y; Chen H; Liu K; Yao M; Wang K; Gu W; Shou T
Cancer Med; 2019 Aug; 8(9):4338-4347. PubMed ID: 31199602
[TBL] [Abstract][Full Text] [Related]
19. [Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of
Small Cell Lung Cancer].
Wu Y; Zhao J; Wang M
Zhongguo Fei Ai Za Zhi; 2023 Apr; 26(4):303-309. PubMed ID: 37183645
[TBL] [Abstract][Full Text] [Related]
20. Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors.
Saber A; Hiltermann TJN; Kok K; Terpstra MM; de Lange K; Timens W; Groen HJM; van den Berg A
Carcinogenesis; 2017 Feb; 38(2):144-151. PubMed ID: 27993895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
